qEEG and Brain Mapping Explained: What These Tests Measure and Why They're Used Alongside Imaging

After a concussion or traumatic brain injury, patients often ask why an evaluation might involve more than one type of test. An MRI or CT scan looks at the brain's physical structure. Quantitative EEG (qEEG) and brain mapping look at something different: the brain's electrical activity, and how efficiently different regions communicate with each other. Understanding what these tests actually measure, and what they don't, helps explain why our physician team frequently uses them alongside imaging rather than in place of it.

What qEEG Actually Measures

A standard EEG records raw electrical activity from the scalp, and a neurologist reviews that recording visually for identifiable patterns. Quantitative EEG takes that same recorded signal and applies statistical analysis: the signal is broken down into measurable features, such as frequency band power, connectivity between regions, and signal complexity, and compared against normative databases built from large samples of people without known neurological injury. According to PubMed, a systematic review of 31 studies found that qEEG frequently detects functional anomalies after traumatic brain injury that standard neuroimaging does not, most consistently increased slow-wave (delta and theta) activity alongside decreased fast-wave (alpha, beta, and gamma) activity, along with reduced connectivity between frontal and parietal regions associated with slower processing speed in some patients (Amico & Koberda, 2023, Clin EEG Neurosci, DOI).

What Brain Mapping Adds

Brain mapping isn't a separate test from qEEG, it's a way of visualizing the same underlying data. Once qEEG has generated statistical comparisons between a patient's brain activity and normative data, brain mapping presents those comparisons as color-coded topographic maps across the scalp, making it easier for the interpreting neurologist to see which regions show activity patterns outside the expected range and to correlate that with a patient's reported symptoms.

Why These Tests Are Used Alongside Imaging, Not Instead of It

Following a concussion, a patient's CT or MRI often comes back structurally normal even when real symptoms persist, because standard imaging is built to detect bleeding, swelling, or fractures, not changes in how the brain's electrical systems are functioning. qEEG and brain mapping are among the tools used to characterize that functional side of an injury. According to PubMed, a 2024 study in JAMA Network Open used qEEG features, including power, connectivity, and signal complexity, to identify distinct resting-state physiological subtypes among more than 700 patients assessed within days of a concussion, and found that subtype membership was statistically associated with time to return to activity (Armañanzas et al., 2024, JAMA Netw Open, DOI). A finding like that supports qEEG's role as a meaningful, evolving tool for characterizing concussion physiology. It does not mean the test can forecast any individual patient's outcome or recovery timeline, and NeuroLUX does not use it to make such predictions.

What the Evidence Does, and Doesn't, Support

It's worth being direct about where the research currently stands. Quantitative EEG remains an active area of investigation, and professional guidance reflects that. According to PubMed, a 2021 practice guideline from the American Clinical Neurophysiology Society reviewed the available evidence and concluded that qEEG, used on its own, does not currently have sufficient evidence to reliably diagnose mild traumatic brain injury, classifying it as an investigational tool for that specific use rather than a standalone diagnostic test (Tenney et al., 2021, J Clin Neurophysiol, DOI). More recent research continues to explore where qEEG adds value: a 2026 study in Neuroscience examining resting-state qEEG in college athletes before and after concussion identified measurable differences in brain activity patterns, while explicitly noting that the clinical utility of these measures has not yet been established (Doucet et al., 2026, Neuroscience, DOI). This is exactly why our physician team never interprets qEEG or brain mapping as a standalone result. Findings are always reviewed alongside a patient's full clinical history, symptom presentation, standard EEG, and any imaging performed, and are never used on their own to diagnose a concussion or to predict how a patient's recovery will unfold.

When These Tests Might Be Part of an Evaluation

qEEG and brain mapping aren't ordered for every patient, and they aren't a first step. Our physician team typically considers them after a clinical history and neurological exam, and often after standard imaging has already been obtained, when a patient continues to report symptoms such as cognitive fog, concentration difficulty, or sensory sensitivity that the exam and imaging alone haven't fully explained. In that setting, qEEG and brain mapping give the physician team an additional, physiologically grounded data point to weigh alongside everything else that's already been gathered, rather than a shortcut that replaces any of it. For patients being seen for personal injury or independent medical examination purposes, that same layered approach, clinical exam, imaging, and functional testing together, is what supports a well-documented record rather than a single test result standing on its own.

Getting Evaluated

Whether qEEG, brain mapping, or another diagnostic tool is appropriate for your situation is a question for a structured evaluation, not a decision to make from test names alone. Learn more about qEEG at NeuroLUX, or schedule an evaluation with the physician team.